Elisa Turlizzi
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Liver physiology and pathology
Papers in
-
- Receptor Mechanisms and Signaling 3
- Nicotinic Acetylcholine Receptors Study 3
- S100 Proteins and Annexins 1
-
- Cholinesterase and Neurodegenerative Diseases 3
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Ugo Zanelli (4 shared papers)David Hallifax (2 shared papers)Mario Monshouwer (1 shared paper)Ruben de Kanter (1 shared paper)J. Brian Houston (1 shared paper)Giuseppe Oliveri (1 shared paper)Pasquale Annunziata (1 shared paper)Chiara Cioni (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)European Journal of Medicinal Chemistry (2 papers)Cell Research (1 paper)ChemMedChem (1 paper)Toxicology (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Elisa Turlizzi
11 papers receiving 278 citations
Peers
Comparison fields: 5 of 60
- Pharmacology 100
- Hepatology 24
- Oncology 64
- Neurology 18
- Computational Theory and Mathematics 32
Countries citing papers authored by Elisa Turlizzi
This map shows the geographic impact of Elisa Turlizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Turlizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Turlizzi more than expected).
Fields of papers citing papers by Elisa Turlizzi
This network shows the impact of papers produced by Elisa Turlizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Turlizzi. The network helps show where Elisa Turlizzi may publish in the future.
Co-authors
The 25 scholars most cited alongside Elisa Turlizzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 71 | |
| 2 | 2011 | 58 | |
| 3 | 2012 | 29 | |
| 4 | 2012 | 21 | |
| 5 | 2011 | 20 | |
| 6 | 2006 | 20 | |
| 7 | 2010 | 16 | |
| 8 | 2014 | 16 | |
| 9 | 2015 | 15 | |
| 10 | 2012 | 12 | |
| 11 | 2006 | 8 |
About Elisa Turlizzi
Elisa Turlizzi is a scholar working on Molecular Biology, Pharmacology, Oncology, Computational Theory and Mathematics and Pharmacology, having authored 11 papers that have together received 286 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Computational Drug Discovery Methods (3 papers), Receptor Mechanisms and Signaling (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Cancer Mechanisms and Therapy (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Pharmacology (100 citations), Hepatology (24 citations), Oncology (64 citations), Neurology (18 citations) and Computational Theory and Mathematics (32 citations). Elisa Turlizzi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Ugo Zanelli, David Hallifax, Mario Monshouwer, Ruben de Kanter, J. Brian Houston, Giuseppe Oliveri, Pasquale Annunziata, Chiara Cioni, J. Brian Houston and Arianna Bonomi. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Cell Research, ChemMedChem and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.